How Vancomycin Should Be Given
Vancomycin should be administered intravenously at 15-20 mg/kg (actual body weight) every 8-12 hours, with each dose infused over at least 60 minutes at a rate not exceeding 10 mg/min, using concentrations no greater than 5 mg/mL to minimize infusion-related reactions. 1, 2
Standard Administration Protocol
Infusion Rate and Concentration
- The infusion rate must not exceed 10 mg/min, and each dose should be administered over at least 60 minutes, whichever is longer. 2
- Concentrations should not exceed 5 mg/mL in most patients to reduce the risk of infusion-related events. 2
- In fluid-restricted patients, concentrations up to 10 mg/mL may be used, but this increases the risk of infusion reactions. 2
- The rate of administration must be monitored closely, as infusion-related events are related to both concentration and rate. 3
Standard Dosing Regimen
- For adults with normal renal function, administer 15-20 mg/kg (actual body weight) every 8-12 hours, not exceeding 2 g per dose. 1
- Traditional fixed doses of 1 g every 12 hours are typically adequate only for non-obese patients with non-severe infections. 1
- Weight-based dosing is critical—fixed dosing of 1 g every 12 hours leads to underdosing in most patients, particularly those weighing >70 kg or with obesity. 1
Loading Dose for Serious Infections
- For seriously ill patients with suspected MRSA infection, sepsis, meningitis, pneumonia, endocarditis, or necrotizing fasciitis, administer a loading dose of 25-30 mg/kg (actual body weight). 1, 4
- The loading dose is essential to rapidly achieve therapeutic concentrations, particularly in critically ill patients with expanded extracellular volume from fluid resuscitation. 1
- When administering loading doses, prolong the infusion time to 2 hours and consider premedication with an antihistamine to reduce the risk of red man syndrome. 1, 4
- The loading dose is NOT affected by renal function—only maintenance doses require adjustment for renal impairment. 1
Therapeutic Monitoring
- Trough concentrations are the most accurate and practical method to guide vancomycin dosing. 1
- Obtain trough levels at steady state, prior to the fourth or fifth dose. 1
- Target trough concentrations of 15-20 μg/mL for serious infections (bacteremia, endocarditis, meningitis, pneumonia, necrotizing fasciitis). 1, 4
- Target trough concentrations of 10-15 μg/mL for non-severe infections. 1
- Peak concentration monitoring is not recommended. 1
- The pharmacodynamic parameter that best predicts efficacy is AUC/MIC >400. 1
Dosing Interval Adjustments
Normal Renal Function
- Administer every 8-12 hours based on infection severity and patient characteristics. 1, 2
- Vancomycin is typically given every 12 hours in outpatient settings due to its attractive dosing characteristics. 3
Renal Impairment
- Dosing intervals must be extended based on creatinine clearance—the initial dose should be at least 15 mg/kg even in mild to moderate renal insufficiency. 2
- For creatinine clearance of 50 mL/min, the daily dose is approximately 770 mg; for 30 mL/min, approximately 465 mg. 2
- In anuria, a dose of 1,000 mg every 7-10 days has been recommended. 2
- The loading dose does NOT require adjustment for renal dysfunction—only maintenance doses are adjusted. 1
Common Pitfalls and How to Avoid Them
- Never use fixed 1 g doses without considering patient weight—this results in underdosing in the majority of patients. 1
- Do not target high trough levels (15-20 μg/mL) for non-severe infections, as this unnecessarily increases nephrotoxicity risk. 1
- Infusion-related events (red man syndrome) can occur at any rate or concentration but are minimized by adhering to the 10 mg/min maximum rate. 2
- If vancomycin MIC is ≥2 μg/mL, consider alternative therapies (daptomycin, linezolid, ceftaroline) as target AUC/MIC ratios may not be achievable. 1, 5
- Nephrotoxicity risk increases significantly with trough levels >15 mg/L, especially when combined with other nephrotoxic agents. 1
- Trough monitoring is mandatory in patients with renal dysfunction, obesity, or fluctuating volumes of distribution. 1
Alternative Administration Method
- Continuous infusion (CI) is used regularly in European countries and offers the advantage of steady-state concentration monitoring rather than trough monitoring. 6
- CI vancomycin may be associated with lower risk of kidney injury compared to intermittent infusion, though findings are equivocal. 6
- CI involves a loading dose of 15-20 mg/kg followed by an infusion of 10-40 mg/kg/day based on renal function, targeting steady-state concentrations of 20-30 mg/L. 6
- A major disadvantage of CI is potential incompatibility with other intravenous medications that need to be co-administered. 6